Single-dose AAV vector gene immunotherapy to treat food allergy

Immunotherapies for patients with food allergy have shown some success in limiting allergic responses. However, these approaches require lengthy protocols with repeated allergen dosing and patients can relapse following discontinuation of treatment. The purpose of this study was to test if a single...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Visiedo, Miguel, Li, Xin, Munoz-Melero, Maite, Kulis, Michael D., Daniell, Henry, Markusic, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361215/
https://www.ncbi.nlm.nih.gov/pubmed/35990748
http://dx.doi.org/10.1016/j.omtm.2022.07.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361215/
https://www.ncbi.nlm.nih.gov/pubmed/35990748
http://dx.doi.org/10.1016/j.omtm.2022.07.008

Ejemplares similares